Sustain 6: a post-hoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects with type 2 diabetes

S. Bellary; E. Jodar; J. Seufert; L.h. Damgaard; A Gaarsdal Holst; L. Leiter

doi:10.1016/j.atherosclerosissup.2018.07.033

Sustain 6: a post-hoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects with type 2 diabetes

S. Bellary
, E. Jodar
, J. Seufert
, L.h. Damgaard
, A Gaarsdal Holst
, L. Leiter

Research output: Contribution to journal › Conference abstract › peer-review

Original language	English
Pages (from-to)	e6-e7
Journal	Atherosclerosis Supplements
Volume	34
DOIs	https://doi.org/10.1016/j.atherosclerosissup.2018.07.033
Publication status	Published - 21 Sept 2018
Event	HEART UK 32nd Annual Medical & Scientific Conference - Warwick, United Kingdom Duration: 4 Jul 2018 → 6 Jul 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.atherosclerosissup.2018.07.033

Cite this

@article{8fe8a7a5287c463ba7ffa97a77d7153c,

title = "Sustain 6: a post-hoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects with type 2 diabetes",

author = "S. Bellary and E. Jodar and J. Seufert and L.h. Damgaard and Holst, \{A Gaarsdal\} and L. Leiter",

year = "2018",

month = sep,

day = "21",

doi = "10.1016/j.atherosclerosissup.2018.07.033",

language = "English",

volume = "34",

pages = "e6--e7",

journal = "Atherosclerosis Supplements",

issn = "1567-5688",

publisher = "Elsevier",

note = "HEART UK 32nd Annual Medical \& Scientific Conference ; Conference date: 04-07-2018 Through 06-07-2018",

}

TY - JOUR

T1 - Sustain 6: a post-hoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects with type 2 diabetes

AU - Bellary, S.

AU - Jodar, E.

AU - Seufert, J.

AU - Damgaard, L.h.

AU - Holst, A Gaarsdal

AU - Leiter, L.

PY - 2018/9/21

Y1 - 2018/9/21

UR - https://linkinghub.elsevier.com/retrieve/pii/S1567568818305245

U2 - 10.1016/j.atherosclerosissup.2018.07.033

DO - 10.1016/j.atherosclerosissup.2018.07.033

M3 - Conference abstract

SN - 1567-5688

VL - 34

SP - e6-e7

JO - Atherosclerosis Supplements

JF - Atherosclerosis Supplements

T2 - HEART UK 32nd Annual Medical & Scientific Conference

Y2 - 4 July 2018 through 6 July 2018

ER -

Sustain 6: a post-hoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects with type 2 diabetes

UN SDGs

Access to Document

Other files and links

Cite this